Black patients with ICDs have higher rate of post-implant cardiac events and risk of death

FHS
July 17, 2023
7:12 pm

Black patients with implantable cardioverter defibrillators (ICDs) have a significantly higher burden of disease than white patients with the same device, according to a new study from University of Rochester Medical Center (URMC) cardiology researchers.

A history of mpox so far

In August, the World Health Organization declared the mpox outbreak in the Democratic Republic of the Congo and several other African countries a public health

September 17, 2024

New tool for tracing blood cells’ ancestry might one day help predict disease risk

The human blood system is in a constant state of turnover. First-line immune defenders, like neutrophils, need to be replaced after just four to eight

January 22, 2024

Aviceda aims to raise $200M; Nerviano gets back rights to PARP1 inhibitor

Plus, news about Maat Pharma, Secretome Therapeutics, 35Pharma, Medigene and Doron Therapeutics: Aviceda Therapeutics’ $200M financing: The Boston-area biotech is looking to raise a …

November 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.